Catalyst Pharmaceuticals concluded January with a robust operational update, showcasing significant strategic momentum. The company's third-quarter results for 2025 revealed...

Despite facing significant headwinds from a volatile cryptocurrency market, Coinbase continues to execute on its long-term expansion strategy. The company's...

Biopharmaceutical company Viking Therapeutics has moved its lead obesity treatment candidate into the final stage of clinical development, following the...

As the market anticipates its upcoming financial release, Iqvia has announced a significant expansion of its strategic footprint through a...

Tilray Brands' latest financial report presents investors with a complex picture. The company achieved its highest-ever quarterly revenue, driven by...

Investors in US utility Evergy are marking their calendars for February 19, 2026. On that date, before US markets open,...

Protalix Biotherapeutics is entering a period defined by significant upcoming regulatory and clinical milestones. Following a strategic update in early...

In a striking market reaction, ServiceNow's stock experienced significant downward pressure following the release of its fourth-quarter results. This occurred...

For the first time in its corporate history, Calix has exceeded one billion dollars in annual revenue. The company's full-year...

A significant realignment is underway within the client portfolio of Taiwan Semiconductor Manufacturing Company (TSMC). The long-standing dominance of Apple...